These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32846785)

  • 1. An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma.
    Wu Z; Ouyang C; Peng L
    Medicine (Baltimore); 2020 Aug; 99(34):e21693. PubMed ID: 32846785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
    Xiao R; Liu C; He W; Ma L
    Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.
    Yue D; Ren C; Li H; Liu X
    Medicine (Baltimore); 2024 Sep; 103(39):e39874. PubMed ID: 39331898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
    Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
    BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC).
    Wu Z; Ouyang C; Peng L
    Med Sci Monit; 2020 Jun; 26():e923231. PubMed ID: 32479428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predicting the 3-year tumor-specific survival in patients with T
    Zhou Z; Deng S; Yan Y; Zhang F; Hao Y; Ge L; Zhang H; Wang G; Zhang S
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Aug; 56(4):673-679. PubMed ID: 39041564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
    Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
    BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
    Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
    BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy.
    Wang K; Guo B; Niu Y; Li G
    BMC Surg; 2024 Jun; 24(1):196. PubMed ID: 38926690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study.
    Ni J; Yao X; Song W; Zhang H; Zhang H; Wang Y; Zhang Y; Wang G; Wang K; Mao W; Peng B
    Cancer Med; 2024 May; 13(9):e7214. PubMed ID: 38686610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
    Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
    Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma.
    Gu J; Zhang X; Peng Z; Peng Z; Liao Z
    Sci Rep; 2023 Nov; 13(1):18922. PubMed ID: 37919459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Risk Stratification Model to Predict Overall Survival and Surgical Benefit in Clear Cell Renal Cell Carcinoma With Distant Metastasis.
    Chen J; Cao N; Li S; Wang Y
    Front Oncol; 2021; 11():630842. PubMed ID: 33777784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.